November 8, 2007
Inaccurate information regarding Abbott's commitment to the FreeStyle Navigator continuous blood glucose monitoring system has been circulated this afternoon. Following are the facts:
FreeStyle Navigator remains under active FDA review and Abbott continues to anticipate a U.S. launch in early 2008. FreeStyle Navigator has been approved in the EU and commercialization is underway. In addition, Abbott is committed to ongoing research and development activities related to future continuous glucose monitoring devices that have the potential to offer patients with diabetes even greater benefits in the management of their disease.
If you have any questions, please call us.
John B Thomas
Vice President, Investor Relations, Abbott
Last Updated: Sunday November 11, 2007 08:42:30
This Internet site provides information of a general nature and is designed for educational purposes only. If you have any concerns about your own health or the health of your child, you should always consult with a physician or other health care professional.
This site is published by Children With Diabetes, Inc, which is responsible for its contents.
© Children with Diabetes, Inc. 1995-2014. Comments and Feedback.